Skip to content
Sign in
Public funderBacked 1 network startup

Connecticut Innovations

Connecticut's state-backed strategic VC, investing in early-stage companies ($45.8M in 67 in FY2025); joined Neurosoft's $7.5M seed.

Rocky Hill, United States ctinnovations.com
Ticket
—Not published
Assets under management
—
Founded
—
Stages
Seedto Series A
Network startups backed
1
Co-investors
3most often with IAG Capital Partners

How they invest

Early-stage companies and funds that build in Connecticut (state mandate, general knowledge); helped attract about US$653M of outside capital in FY2025. Network deal: Neurosoft Bioelectronics (BCI) seed.

Stage and ticket

Seed and Series A.

Geography

United States (Connecticut).

What makes them say yes

  • Connecticut presence or relocation commitment (general knowledge)
  • Outside lead investor
  • Life sciences/tech with job creation

Red flags

  • No Connecticut nexus
  • Unknown

Sectors

Not published

Stages

  • Seed
  • Series A

Geographies

  • United States

How to approach

Approach CEO Matt McCooe or Peter Longo with a Connecticut operations plan; Neurosoft (network peer) can describe the process.

Partners

  • Matt McCooeCEO
  • Peter LongoSenior Managing Director of Investments

Portfolio

1 network startup · no other company

Neurosoft Bioelectronics (Swiss neurotech, oversubscribed seed): CI backs medtech willing to build in Connecticut.

Gaps in the portfolio

  • No network kidney-care or drug-delivery medtech in portfolio

Network startups

  • Neurosoft BioelectronicsSWC 2026 Finalist

    Switzerland · MedTech & devices

    EPFL spin-off making soft, stretchable cortical electrodes for minimally invasive brain interfaces, with first-in-human epilepsy data and a $7.5M seed.

    • Seed (oversubscribed)Source$7.5M ·

Network startups that fit

3 analysed

FDA-cleared low-cost automated peritoneal dialysis cycler, built in a DRAP-approved Pakistani factory, preparing first US patients.

At-home peritoneal dialysis with FDA 510(k) clearance (May 2025): US medtech at commercial scale-up, seed.

35%confidence

Evidence from the records

  • “At-home peritoneal dialysis”
  • “FDA 510(k) clearance K243371”
Intro path
Neurosoft (CI portfolio, medtech peer)
First step
Evaluate a Connecticut site, then pitch CI.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with IAG Capital Partners, PL Capital (Protocol Labs), and Skybound Venture Capital

Sources